"The OSC has made a threshold determination that HHS [Department of Health and Human Services] violated the Whistleblower Protection Act by removing Dr. Bright from his position because he made protected disclosures in the best interest of the American public," Bright's lawyers, Debra Katz and Lisa Banks, said in a joint statement. An analysis released last month found that COVID-19 patients in U.S. veteran hospitals who were treated with the drug found no benefit. In his whistleblower complaint, Bright said he opposed the use of the drug, arguing its lack of scientific evidence to justify treating coronavirus patients. "This country is in an unprecedented health crisis and needs the expertise of Dr.

Source: Fox News May 08, 2020 22:30 UTC